Sono-Tek Corporation Reports Q2 Profit Increase, Revenue Remains Stable
ByAinvest
Tuesday, Oct 14, 2025 7:46 am ET1min read
SOTK--
The Milton, New York-based company's gross profit margin remained stable at 50%, while its net income grew by 24% YOY. The company's backlog increased by 50% sequentially, driven primarily by the medical market, which saw a 150% YOY increase in sales. This growth was attributed to the strong demand for balloon coating systems [1].
Analysts had expected Sono-Tek to report $5.20 million in revenue for the quarter, with an EPS of $0.02 per share. The company's actual results slightly missed the revenue estimate but beat the EPS forecast. The current average analyst rating on the shares is "buy," with a breakdown of 1 "strong buy" or "buy," 1 "hold," and no "sell" or "strong sell" recommendations [^1, 2].
Sono-Tek's stock recently traded at 48 times the next 12-month earnings, compared to a P/E ratio of 64 three months ago. The Wall Street median 12-month price target for Sono-Tek is $7.75, about 45.8% above its October 13 closing price of $4.20 [^1, 2].
The company remains optimistic about its future prospects, particularly in the medical device market, despite uncertainties in the clean energy sector. Sono-Tek expects modest revenue growth for the fiscal year 2026, driven by growing demand in the medical market [1].
Sono-Tek Corporation reported a Q2 profit of $423.69 million, up from $340.68 million last year. The company's revenue rose 0.0% to $5.162 billion from $5.161 billion last year. The earnings per share (EPS) increased to $0.03 from $0.02 last year.
Sono-Tek Corporation (NASDAQ: SONO) reported its Q2 earnings on September 12, 2025, with a net income of $424,000, up 24% year-over-year (YOY) to $0.03 per share. Despite a flat revenue of $5.163 million, the company's earnings per share (EPS) increased to $0.03 from $0.02 a year ago [1].The Milton, New York-based company's gross profit margin remained stable at 50%, while its net income grew by 24% YOY. The company's backlog increased by 50% sequentially, driven primarily by the medical market, which saw a 150% YOY increase in sales. This growth was attributed to the strong demand for balloon coating systems [1].
Analysts had expected Sono-Tek to report $5.20 million in revenue for the quarter, with an EPS of $0.02 per share. The company's actual results slightly missed the revenue estimate but beat the EPS forecast. The current average analyst rating on the shares is "buy," with a breakdown of 1 "strong buy" or "buy," 1 "hold," and no "sell" or "strong sell" recommendations [^1, 2].
Sono-Tek's stock recently traded at 48 times the next 12-month earnings, compared to a P/E ratio of 64 three months ago. The Wall Street median 12-month price target for Sono-Tek is $7.75, about 45.8% above its October 13 closing price of $4.20 [^1, 2].
The company remains optimistic about its future prospects, particularly in the medical device market, despite uncertainties in the clean energy sector. Sono-Tek expects modest revenue growth for the fiscal year 2026, driven by growing demand in the medical market [1].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet